Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Interaction Between SHR4640 and Furosemide
NCT04850638Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jun 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ruzinurad in hyperuricemia and gout, sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from Time 0 to Last Measurable Concentration and 3 more. Started Jun 2021; status: completed.
02
Drugs
ruzinurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on NCT04850638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04850638.